BHLHE22
Class E basic helix-loop-helix protein 22
Also known as: Beta3, BHE22_HUMAN, BHLHB5, CAGL85, TNRC20
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8NFJ8
- Gene
- BHLHE22
- Ensembl
- ENSG00000180828
- Chromosome
- 8
- Canonical length
- 381 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear speckles,Centrosome,Cytosol
OverviewNCBI Gene
This gene encodes a protein that belongs to the basic helix-loop-helix (bHLH) family of transcription factors that regulate cell fate determination, proliferation, and differentiation. A similar protein in mouse is required for the development of the dorsal cochlear nuclei, and is thought to play a role in in the differentiation of neurons involved in sensory input. The mouse protein also functions in retinogenesis. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
381 residues, UniProt reviewed canonical sequence.
>Q8NFJ8|BHLHE22
1 MERGMHLGAA AAGEDDLFLH KSLSASTSKR LEAAFRSTPP GMDLSLAPPP RERPASSSSS
61 PLGCFEPADP EGAGLLLPPP GGGGGGSAGS GGGGGGGVGV PGLLVGSAGV GGDPSLSSLP
121 AGAALCLKYG ESASRGSVAE SSGGEQSPDD DSDGRCELVL RAGVADPRAS PGAGGGGAKA
181 AEGCSNAHLH GGASVPPGGL GGGGGGGSSS GSSGGGGGSG SGSGGSSSSS SSSSKKSKEQ
241 KALRLNINAR ERRRMHDLND ALDELRAVIP YAHSPSVRKL SKIATLLLAK NYILMQAQAL
301 EEMRRLVAYL NQGQAISAAS LPSSAAAAAA AAALHPALGA YEQAAGYPFS AGLPPAASCP
361 EKCALFNSVS SSLCKQCTEK PLocalizationUniProt · AlphaFold · HPA
Whether an antibody against BHLHE22 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.67
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- hippocampal formation: 23 nTPM
- cerebellum: 17 nTPM
- amygdala: 14 nTPM
- cerebral cortex: 7.3 nTPM
- retina: 4.1 nTPM
- spinal cord: 3.1 nTPM
Single-cell type
- retinal amacrine cells: 83 nCPM
- retinal bipolar cells: 42 nCPM
- brain inhibitory neurons: 11 nCPM
- lactotrophs: 9.7 nCPM
- brain excitatory neurons: 7.9 nCPM
- vascular smooth muscle cells: 6 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hippocampal formation: 49 nTPM
- cerebral cortex: 48 nTPM
- cerebellum: 25 nTPM
- amygdala: 19 nTPM
- basal ganglia: 14 nTPM
- medulla oblongata: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about BHLHE22.
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 74 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- BHLHE22-related disorder
- See cases
Disease | AutoantibodyPubMed
Conditions in which antibodies against BHLHE22 are reported. Each links to that disease's full target list.
Showing 0 of 1 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for BHLHE22 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
11 publications
- A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy.
2006 · Blood · RCR 1.4 · 63 citations - Anti-epiligrin cicatricial pemphigoid with IgG autoantibodies to the beta and gamma subunits of laminin 5.
1999 · J Am Acad Dermatol · RCR 0.8 · 23 citations - Maternal Anti-HPA-1a Antibodies Increase Endothelial Cell Apoptosis and Permeability.
2021 · J Vasc Res · RCR 0.5 · 7 citations - Platelet fragmentation requires a specific structural conformation of human monoclonal antibody against beta3 integrin.
2008 · J Biol Chem · RCR 0.4 · 17 citations - Relationship between the autoantibody and expression of β3-adrenoceptor in lung and heart.
2013 · PLoS One · RCR 0.4 · 10 citations
Show 6 more
- Presence of platelet-associated anti-glycoprotein (GP)VI autoantibodies and restoration of GPVI expression in patients with GPVI deficiency.
2009 · J Thromb Haemost · RCR 0.3 · 11 citations - Autoantibodies against the β3-adrenoceptor protect from cardiac dysfunction in a rat model of pressure overload.
2013 · PLoS One · RCR 0.3 · 7 citations - A case of mucous membrane pemphigoid with IgG antibodies against the β3 and γ2 subunits of laminin-332, and the C-terminal domain of BP180.
2018 · Int J Dermatol · RCR 0.2 · 3 citations - A case of mucous membrane pemphigoid with anti-laminin alpha 3 and beta 3 antibodies initially mimicking Stevens-Johnson syndrome.
2022 · Int J Dermatol · RCR 0.2 · 1 citations - Cardiac effects of long-term active immunization with the second extracellular loop of human β1- and/or β3-adrenoceptors in Lewis rats.
2015 · Pharmacol Res · RCR 0.1 · 3 citations - [Cardiovascular effects of beta1 and beta3-adrenergic receptor autoantibodies in Lewis rat].
2014 · Ann Cardiol Angeiol (Paris) · RCR 0.1 · 2 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.56
- gnomAD pLI
- 0.8
- gnomAD missense Z
- 1.31
- DepMap mean gene effect
- -0.05
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- DNA-binding transcription factor activity, RNA polymerase II-specific
- E-box binding
- protein dimerization activity
- sequence-specific double-stranded DNA binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of BHLHE22 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads BHLHE22 as an antibody target. Whether an autoantibody or antibody against BHLHE22 could matter depends on whether native BHLHE22 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
BHLHE22 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label BHLHE22 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...